He Feifan, Wang Shaoming, Zheng Rongshou, Gu Jianhua, Zeng Hongmei, Sun Kexin, Chen Ru, Li Li, Han Bingfeng, Li Xinqing, Wei Wenqiang, He Jie
Office of National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Lancet Reg Health West Pac. 2024 Jan 6;44:101003. doi: 10.1016/j.lanwpc.2023.101003. eCollection 2024 Mar.
The incidence of gastric cancer (GC) decreased in past decades, which was thought largely attributable to risk factors control, yet China still accounts for 44% of global GC burdens. We aimed to estimate changing trajectories of proportions of GC burdens attributable to modifiable risk factors from 2000 to 2050 in China, to inform future targeted preventive strategies.
The incidence and new cases of GC were predicted to 2050 using Bayesian age-period-cohort model based on incidence data by anatomical subsites drawn from 682 cancer registries from National Central Cancer Registry. Population attributable fractions (PAFs) were calculated based on prevalence of risk factors and relative risks with GC. Temporal trends of PAFs were described by sex and categories of risk factors using joinpoint analysis.
We observed declining trends of PAFs of () infection, smoking, pickled vegetable and alcohol consumption, but increasing trends of PAFs of unhealthy body mass index and diabetes for GC in China. The combined PAFs of these risk factors were estimated to decrease by 10.57% from 2000 to 2050 for GC. We estimated there will be 279,707 GC (122,796 cardia gastric cancer [CGC] and 156,911 non-cardia gastric cancer [NCGC]) cases in 2050. Out of these cases, 70.18% of GC cases could be attributable to modifiable risk factors, while infection was predicted to be responsible for 40.7% of CGC and 62.1% of NCGC cases in 2050.
More than half of GC remained attributable to modifiable risk factors in China. Continued effective strategies on risk factors control are needed to reduce the burden of this highly life-threatening cancer in future.
Beijing Nova Program (No. Z201100006820069), CAMS Innovation Fund for Medical Sciences (CIFMS, grant No. 2021-I2M-1-023), CAMS Innovation Fund for Medical Sciences (CIFMS, grant No. 2021-I2M-1-010), Talent Incentive Program of Cancer Hospital Chinese Academy of Medical Sciences (Hope Star).
过去几十年间,胃癌(GC)发病率有所下降,这在很大程度上被认为归因于风险因素的控制,但中国仍占全球胃癌负担的44%。我们旨在估计2000年至2050年期间中国可改变风险因素所致胃癌负担比例的变化轨迹,为未来有针对性的预防策略提供依据。
基于国家癌症中心682个癌症登记处按解剖亚部位划分的发病率数据,使用贝叶斯年龄-时期-队列模型预测到2050年的胃癌发病率和新发病例数。根据风险因素的患病率和与胃癌的相对风险计算人群归因分数(PAF)。使用连接点分析按性别和风险因素类别描述PAF的时间趋势。
我们观察到中国胃癌中幽门螺杆菌()感染、吸烟、腌制蔬菜和饮酒的PAF呈下降趋势,但不健康体重指数和糖尿病的PAF呈上升趋势。这些风险因素的综合PAF估计在2000年至2050年期间因胃癌而下降10.57%。我们估计2050年将有279,707例胃癌(122,796例贲门胃癌[CGC]和156,911例非贲门胃癌[NCGC])病例。在这些病例中,70.18%的胃癌病例可归因于可改变的风险因素,而预计2050年幽门螺杆菌感染将导致40.7%的CGC病例和62.1%的NCGC病例。
在中国,超过一半的胃癌仍可归因于可改变的风险因素。未来需要持续采取有效的风险因素控制策略,以减轻这种严重威胁生命的癌症的负担。
北京新星计划(编号Z201100006820069)、中国医学科学院医学创新基金(CIFMS,资助编号2021-I2M-1-023)、中国医学科学院医学创新基金(CIFMS,资助编号2021-I2M-1-010)、中国医学科学院肿瘤医院人才激励计划(希望之星) 。